With the continual development of new health products, cybersecurity teams are discovering new vulnerabilities and threats each day. Cybersecurity teams must not only develop secured products that ensure patient safety is protected, they must also work to maintain products in the field and ensure compliance with constant updated guidance. Medical device manufactures much test and continually monitor product safety to ensure risks are not exploited as devices age and become more vulnerable.

发言人:: Kimberly J. Gold

活动类型: 网络研讨会

开始日期/时间:
28 September 2020, 8:00 AM CDT
结束日期/时间:
30 September 2020, 12:15 PM CDT

This year’s Medical Device Cybersecurity Risk Mitigation Conference will virtually connect security leaders to share best practices in the following modules:

  • Module 1: Managing Cybersecurity Risk Through Various Assessments & Robust Management Systems
  • Module 2: Cybersecurity Collaboration Between MDMs & HDOs to Ensure Patient Safety
  • Module 3: Considerations for Compliance with Regulatory Guidelines & Privacy Requirements

Join Reed Smith partner Kim Gold during Module 2, for her presentation "Legal Perspective: Application of Essential Cybersecurity Controls for Regulated Software." 

Medical devices employ software to innovate technology as well as establish mobility and depending on the capabilities or intended use, the product could be within FDA oversight. The classification of software and level of regulation determines the approach to controlling cyber constituents and security considerations. Manufacturers must manage software vendors and modifications that occur in the coding, type of connection, and changes outside the supplier domain, such as updates to operating systems to mitigate vulnerabilities.

 For more information, or to register, visit q1productions.com.